Literature DB >> 29153269

Vitamin D pathway gene polymorphisms influenced vitamin D level among pregnant women.

Bule Shao1, Shuying Jiang1, Xiamusiye Muyiduli1, Shuojia Wang1, Minjia Mo1, Minchao Li1, Zhaopin Wang1, Yunxian Yu2.   

Abstract

AIMS: To explore the relationship between vitamin D pathway genes, gene-environment interactions and vitamin D level among southeast Chinese pregnant women.
METHODS: 759 participants from Zhoushan Pregnant Women Cohort (ZPWC) study, were enrolled from August 2011 to April 2014 in China. Plasma 25(OH)D levels and genetic variants in vitamin D pathway (NADSYN1/DHCR7, GC, CYP3A4, CYP2R1, CYP27A1, CYP27B1, VDR, CYP24A1, and LRP2) were measured using the blood sample collected at the first trimester. Information on demographics, lifestyle, and health behavior were collected using a questionnaire. Multilinear regression and logistic regression models were performed to estimate the associations between SNPs and 25(OH)D level.
RESULTS: Mean plasma 25(OH)D concentrations were 15.6 ng/mL among the pregnant women. Variants of GC rs16846876, rs17467825, rs2282679, rs3755967, rs2298850, rs4588, rs7041 and rs1155563, CYP3A4 rs2242480 and CYP24A1 rs2209314 were significantly associated with both 25(OH)D concentrations and vitamin D deficiency (25(OH)D < 15 ng/mL). Variants of NADSYN1/DHCR7 were significantly associated with 25(OH)D concentrations among pregnant women without vitamin D supplements. Pregnant women with vitamin D binding protein (Gc) Gc-1f (P = 0.02) and Gc-1s (P = 0.005) had higher plasma 25(OH)D levels compared to women with Gc-2. Genotype risk score (GRS) calculated from rs7041, rs2242480 and rs2209314 shown a significantly negative association with 25(OH)D levels. Participants with GRS > 3 had a higher risk for vitamin D deficiency than individuals with GRS ≤ 3 (OR = 1.71, 95% CI = 1.25-2.35). Interactions between seasons and CYP27A1 rs933994, CYP3A4 rs2246709 on plasma 25(OH)D concentrations were also observed. Haplotypes of GC and LRP2 genes shown significant associations with 25(OH)D levels among pregnant women, respectively.
CONCLUSIONS: Genetic mutants in vitamin D pathway (GC, CYP3A4, CYP24A1, and NADSYN1/DHCR7) had significant associations with 25(OH)D levels among pregnant women in southeast China. Furthermore, their associations were modified by vitamin D supplementation and season.
Copyright © 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  CYP24A1; CYP3A4; GC; NADSYN1/DHCR7; Pregnancy; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 29153269     DOI: 10.1016/j.clnu.2017.10.024

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  26 in total

1.  Ancestry-specific polygenic scores and SNP heritability of 25(OH)D in African- and European-ancestry populations.

Authors:  Kathryn E Hatchell; Qiongshi Lu; Scott J Hebbring; Erin D Michos; Alexis C Wood; Corinne D Engelman
Journal:  Hum Genet       Date:  2019-07-24       Impact factor: 4.132

Review 2.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

3.  Maternal and Fetal Genetic Variation in Vitamin D Metabolism and Umbilical Cord Blood 25-Hydroxyvitamin D.

Authors:  Rebecca J Moon; Laura D F Cooke; Stefania D'Angelo; Elizabeth M Curtis; Philip Titcombe; Justin H Davies; Keith M Godfrey; Jane K Cleal; Rohan M Lewis; Cyrus Cooper; Nicholas C Harvey
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

Review 4.  Gene-Environment Interactions in Vitamin D Status and Sun Exposure: A Systematic Review with Recommendations for Future Research.

Authors:  Rasha Shraim; Conor MacDonnchadha; Lauren Vrbanic; Ross McManus; Lina Zgaga
Journal:  Nutrients       Date:  2022-06-30       Impact factor: 6.706

5.  Risk factors for vitamin D deficiency in sickle cell disease.

Authors:  Jin Han; Xu Zhang; Santosh L Saraf; Michel Gowhari; Robert E Molokie; Johara Hassan; Shivi Jain; Binal N Shah; Taimur Abbasi; Roberto F Machado; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2018-05-16       Impact factor: 6.998

6.  Genetic Contributions to Maternal and Neonatal Vitamin D Levels.

Authors:  Michela Traglia; Gayle C Windham; Michelle Pearl; Victor Poon; Darryl Eyles; Karen L Jones; Kristen Lyall; Martin Kharrazi; Lisa A Croen; Lauren A Weiss
Journal:  Genetics       Date:  2020-02-11       Impact factor: 4.562

7.  Multiple genetic factors affecting the pharmacokinetic and pharmacodynamic processes of tacrolimus in Chinese myasthenia gravis patients.

Authors:  Huan-Yu Meng; Xi Li; Wan-Lin Jin; Cheng-Kai Yan; Xiao-Hua Dong; Qiu Xu; Yu-Yao Peng; Zhi-Bin Li; Yi Li; Zhao-Hui Luo; Li-Qun Xu; Huan Yang
Journal:  Eur J Clin Pharmacol       Date:  2020-01-18       Impact factor: 2.953

8.  Influences of Vitamin D Levels and Vitamin D-Binding Protein Polymorphisms on Nonalcoholic Fatty Liver Disease Risk in a Chinese Population.

Authors:  Min Wang; Minxian Wang; Ru Zhang; Chao Shen; Liuxin Zhang; Yajie Ding; Zongzhe Tang; Hongliang Wang; Wei Zhang; Yue Chen; Jie Wang
Journal:  Ann Nutr Metab       Date:  2022-01-31       Impact factor: 5.923

Review 9.  Deconvoluting the Biological Roles of Vitamin D-Binding Protein During Pregnancy: A Both Clinical and Theoretical Challenge.

Authors:  Spyridon N Karras; Theocharis Koufakis; Hana Fakhoury; Kalliopi Kotsa
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-23       Impact factor: 5.555

10.  A genetic approach to study the relationship between maternal Vitamin D status and newborn anthropometry measurements: the Vitamin D pregnant mother (VDPM) cohort study.

Authors:  Arif Sabta Aji; Erwinda Erwinda; Rosfita Rasyid; Yusrawati Yusrawati; Safarina G Malik; Buthaina Alathari; Julie Anne Lovegrove; Nur Indrawaty Lipoeto; Karani Santhanakrishnan Vimaleswaran
Journal:  J Diabetes Metab Disord       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.